BioDerm has partnered with Eloquest Healthcare, a wholly owned subsidiary of Ferndale Pharma Group, to introduce its next generation urinary management devices into the acute care market. BioDerm is the manufacturer of the ReliaFit male ...
US-based Eloquest Healthcare has launched ReliaFit Male Urinary Device, a next-generation external catheter that reduces the risk of urinary tract infections usually related with indwelling catheters. ReliaFit also offers a high level of ...
Tags: Male Urinary Device, Health